143
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Screening of coexisting depression or anxiety disorders among Danish patients with alcohol use disorder in outpatient treatment

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 608-616 | Received 16 Nov 2022, Accepted 30 Mar 2023, Published online: 24 Apr 2023

References

  • Lim GY, Tam WW, Lu Y, et al. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018;8(1):2861.
  • Baxter AJ, Scott KM, Vos T, et al. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43(5):897–910.
  • Hunt GE, Malhi GS, Lai HMX, et al. Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990–2019: systematic review and meta-analysis. J Affect Disord. 2020;266:288–304.
  • Burns L, Teesson M, O’Neill K. The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction. 2005;100(6):787–796.
  • Flensborg-Madsen T, Mortensen EL, Knop J, et al. Comorbidity and temporal ordering of alcohol use disorders and other psychiatric disorders: results from a Danish register-based study. Compr Psychiatry. 2009;50(4):307–314.
  • Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med. 2005;118(4):330–341.
  • Baker AL, Thornton LK, Hiles S, et al. Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: a systematic review. J Affect Disord. 2012;139(3):217–229.
  • Hobbs JD, Kushner MG, Lee SS, et al. Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. Am J Addict. 2011;20(4):319–329.
  • Caspi A, Houts RM, Belsky DW, et al. The p factor: one general psychopathology factor in the structure of psychiatric disorders? Clin Psychol Sci. 2014;2(2):119–137.
  • Saha S, Lim CCW, Cannon DL, et al. Co-morbidity between mood and anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2021;38(3):286–306.
  • Solis EC, van Hemert AM, Carlier IVE, et al. The 9-year clinical course of depressive and anxiety disorders: new NESDA findings. J Affect Disord. 2021;295:1269–1279.
  • Sundhedsstyrelsen. Den nationale kliniske retningslinje for udredning og behandling af samtidig alkoholafhængighed og psykisk lidelse. [In Danish]. 2016:1–69.
  • Preuss UW, Gouzoulis-Mayfrank E, Havemann-Reinecke U, et al. Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines. Eur Arch Psychiatry Clin Neurosci. 2018;268(3):219–229.
  • Hakobyan S, Vazirian S, Lee-Cheong S, et al. Concurrent disorder management guidelines. Systematic Review. J Clin Med. 2020;9(8):2406.
  • Helsedirektoratet. Nasjonal faglig retningslinje for utredning, behandling og oppfølgning av personer med samtidig rus-og psykisk lidelse-ROP-lidelser. Oslo: Helsedirektoratet; 2012.
  • Bech P, Timmerby N. An overview of which health domains to consider and when to apply them in measurement-based care for depression and anxiety disorders. Nord J Psychiatry. 2018;72(5):367–373.
  • Kroenke K, Spitzer RL, Williams JB, et al. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–359.
  • Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097.
  • Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959–976.
  • Hesse M, Thylstrup B. Screening substance-dependent patients for mental disorders with the kessler-6. J Dual Diagn. 2012;8(3):229–237.
  • World Health Organisation. A user’s guide to the self reporting questionaire (SRQ). Geneva: World Health Organisation; 1994.
  • Schuckit MA. Comorbidity between substance use disorders and psychiatric conditions. Addiction. 2006;101 (Suppl 1):76–88.
  • Nielsen AS, Nielsen B. Implementation of a clinical pathway may improve alcohol treatment outcome. Addict Sci Clin Pract. 2015;10(1):7.
  • McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992;9(3):199–213.
  • Levis B, Benedetti A, Thombs BD. Accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476.
  • Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325.
  • Plummer F, Manea L, Trepel D, et al. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24–31.
  • Furukawa TA, Kessler RC, Slade T, et al. The performance of the K6 and K10 screening scales for psychological distress in the Australian national survey of mental health and well-being. Psychol Med. 2003;33(2):357–362.
  • Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184–189.
  • Harpham T, Reichenheim M, Oser R, et al. Measuring mental health in a cost-effective manner. Health Policy Plan. 2003;18(3):344–349.
  • Rijnders CA, van den Berg JF, Hodiamont PP, et al. Psychometric properties of the schedules for clinical assessment in neuropsychiatry (SCAN-2.1). Soc Psychiatry Psychiatr Epidemiol. 2000;35(8):348–352.
  • Munk-Jørgensen P, Jørgensen P. Brug af present state examination (PSE) i psykiatriuddannelsen - en pilotundersøgelse. Nordic J Psychiatr. 2009;39(3):189–194.
  • WHO. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization. 1992.
  • Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96(5):644–647.
  • Fischer JE, Bachmann L, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29(7):1043–1051.
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845.
  • Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35.
  • Delgadillo J, Payne S, Gilbody S, et al. How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires. J Affect Disord. 2011;134(1-3):266–271.
  • Delgadillo J, Payne S, Gilbody S, et al. Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment. Drug Alcohol Depend. 2012;125(1-2):37–42.
  • Arnaud B, Malet L, Teissedre F, et al. Validity study of Kessler’s psychological distress scales conducted among patients admitted to french emergency department for alcohol consumption-related disorders. Alcohol Clin Exp Res. 2010;34(7):1235–1245.
  • Lee NK, Jenner L. Development of the PsyCheck screening tool: an instrument for detecting common mental health conditions among substance use treatment clients. Mental Health and Substance Use Dual Diagnosis. 2010;3(1):56–65.
  • Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981;211(4481):453–458.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.